Studi in Silico Senyawa Fitokimia Daun Ketepeng Cina (Cassia alata) sebagai kandidat antibakteri Staphylococcus aureus Penyebab Impetigo
Abstract
This study aimed to analyze the potential of phytochemical compounds from Cassia alata leaves — emodin, chrysophanol, rhein, kaempferol, quercetin, and physcion — as antibacterial candidates against the FtsZ protein (Staphylococcus aureus, PDB ID: 4DXD), the cause of impetigo. The method used was molecular docking. The results showed that kaempferol had the best binding affinity (-9.6 kcal/mol), followed by rhein and quercetin (-9.2 kcal/mol), with key interactions consisting of hydrogen bonds at residues THR309, ASN263, and GLY196, as well as hydrophobic interactions at residues LEU200 and VAL297. All compounds complied with Lipinski's Rule of Five (0 violations, bioavailability 0.55–0.56) and were non-carcinogenic, although some showed hepatotoxicity potential (LD50 1190–5000 mg/kg, class IV–V); bioactivity prediction further confirmed high antibacterial potential. In conclusion, kaempferol and rhein were recommended as promising candidates for further verification, given the existing resistance to antibiotics such as levofloxacin.
Keywords: Cassia alata, FtsZ, Kaempferol, Molecular Docking
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.